beta-D-Galp-(1->3)-[beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->6)]-beta-D-GalpNAc

Term ID

CHEBI:68587

Synonyms

beta-D-Gal-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)]-beta-D-GalNAc
beta-D-galactopyranosyl-(1->3)-[beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->6)]-2-acetamido-2-deoxy-beta-D-galactopyranose
beta-D-galactosyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-N-acetyl-beta-D-galactosamine
Galbeta1-3-(Galbeta1-4GlcNacbeta1-6)GalNAcbeta

Definition

β-D-Galp-(1→3)-[β-D-Galp-(1→4)-β-D-GlcpNAc-(1→6)]-D-GalpNAc with β-configuration at the anomeric centre of the reducing-end GalNAc residue.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Galp-(1->3)-[beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->6)]-beta-D-GalpNAc

Phenotype where environments contain beta-D-Galp-(1->3)-[beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->6)]-beta-D-GalpNAc

Phenotype modified by environments containing beta-D-Galp-(1->3)-[beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->6)]-beta-D-GalpNAc

Phenotype affecting beta-D-Galp-(1->3)-[beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->6)]-beta-D-GalpNAc

Human Disease Model